The documentary special "Living Proof," produced by Sheryl Lee Ralph, will premiere on Hulu on Dec. 1 in honor of World AIDS ...
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
It will unfold alongside the G20 Leaders Summit, creating a two-tier stage where economic and health decisions mingle, ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
The transition to outsourced offshore upstream manufacturing is expected to deliver substantial improvements in gross margin, EBITDA and cashflow generation. The move is part of a broader strategic ...
The US has started to provide doses of a Gilead HIV prevention drug to low-income countries, but the program will not include ...
Franklin County commissioners Rocky Mullen and Clint Didier opposed the increases, while Benton County commissioners Michael ...
The Pennsylvania Department of Health will cut 25% of funding to the Part B of the Ryan White HIV/AIDS Program amid rising ...
Tennessee Gov. Bill Lee said the state had applied for a federal grant funding for rural healthcare, hoping for a piece of ...